High-dose interferon alpha-2b significantly prolongs relaps-free and overall survial compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIb-III melanoma: Results of intergroup trial E1694/S9512/C509801. - Kirkwood,J.M.; Ibrahim,J.G.; Sosman,J.A.; Sondak,V.K.; Agarwala,S.S.; Ernstoff,M.S.; Rao,U. (J Clin Oncol, 2001)